Aktiesnakken — August 2012
-
ser sådan ud
-
de er ret utålmodige, hvis de ikke engang kan lade det modne en dag eller 2
-
det bliver spændende at se luk og så morgendagen
-
ja det er trods alt noget. Men okay, ud af en markedsværdi på 3 mia
-
de får vekslet en del
-
de har åbenbart så travlt
-
hvorfor har Celgene lige optaget et 1,5 mia dollar stort obligationslån
-
Celgene expects to use the net proceeds from the offering for general corporate purposes, which may include, without limitation, further development of Celgene’s clinical and pre-clinical programs, capital expenditures, general corporate development activities and meeting working capital needs.
-
celgene fører iøvrigt revlimid i Multiple Myeloma
-
hvorhenne?
-
er det [email protected]
-
yep
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind